0,979  0,001  Antihypercholesterolemic
0,965  0,001  Cholesterol antagonist
0,944  0,003  Carcinogenic
0,906  0,004  Teratogen
0,899  0,004  Embryotoxic
0,899  0,004  CYP3A4 substrate
0,898  0,005  Antiinflammatory
0,893  0,002  Hair growth stimulant
0,862  0,003  NOS3 expression inhibitor
0,859  0,009  Transcription factor NF kappa B inhibitor
0,842  0,004  Chemopreventive
0,841  0,004  Bone diseases treatment
0,839  0,003  Proliferative diseases treatment
0,846  0,011  Apoptosis agonist
0,819  0,002  UGT1A4 substrate
0,802  0,004  Antiosteoporotic
0,794  0,003  Sulfotransferase substrate
0,791  0,005  Antipsoriatic
0,783  0,005  CYP2C19 substrate
0,778  0,005  Immunomodulator
0,776  0,003  UGT2B1 substrate
0,767  0,004  CTGF expression inhibitor
0,755  0,010  TNF expression inhibitor
0,739  0,005  Lipoprotein disorders treatment
0,737  0,008  Respiratory analeptic
0,715  0,003  Anesthetic
0,712  0,003  Antiparkinsonian, rigidity relieving
0,699  0,002  Antihyperlipoproteinemic
0,701  0,004  Amyotrophic lateral sclerosis treatment
0,691  0,002  UGT2B4 substrate
0,691  0,003  Anesthetic general
0,692  0,005  Hepatic disorders treatment
0,689  0,004  Prostatic (benign) hyperplasia treatment
0,687  0,003  Androgen antagonist
0,681  0,001  Cholesterol synthesis inhibitor
0,684  0,009  Sensitization
0,681  0,008  Atherosclerosis treatment
0,674  0,002  Pregnane X receptor agonist
0,677  0,014  CYP2C9 substrate
0,652  0,006  Antipruritic, allergic
0,641  0,004  Interleukin agonist
0,649  0,013  Prostate cancer treatment
0,635  0,005  UDP-glucuronosyltransferase substrate
0,627  0,002  DNA polymerase I inhibitor
0,652  0,027  Antineoplastic (breast cancer)
0,628  0,004  Diuretic
0,626  0,005  Hypolipemic
0,637  0,021  Antidiabetic
0,637  0,021  Cyclophilin D inhibitor
0,616  0,002  Interferon gamma antagonist
0,628  0,014  Chemoprotective
0,615  0,011  Immunosuppressant
0,598  0,002  UGT2B7 substrate
0,602  0,014  Radioprotector
0,596  0,011  Antineoplastic (pancreatic cancer)
0,600  0,023  Alzheimer's disease treatment
0,592  0,018  Immunostimulant
0,586  0,013  Cytotoxic
0,587  0,014  Analeptic
0,574  0,004  Antiacne
0,566  0,003  Abortion inducer
0,574  0,012  Apoptosis antagonist
0,563  0,012  Nitric oxide antagonist
0,547  0,003  Autism spectrum disorders treatment
0,540  0,002  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,538  0,005  Interleukin 2 agonist
0,534  0,003  Prostate disorders treatment
0,540  0,015  Antifungal
0,529  0,005  Contraceptive
0,552  0,028  Antiobesity
0,517  0,003  Sodium/bile acid cotransporter inhibitor
0,544  0,032  Antileukemic
0,519  0,009  UGT1A1 substrate
0,533  0,023  Antineoplastic (ovarian cancer)
0,500  0,002  Liver X receptor alpha agonist
0,515  0,017  NOS2 expression inhibitor
0,498  0,003  Antipruritic, non-allergic
0,501  0,009  Antineoplastic (liver cancer)
0,510  0,019  Caspase 3 stimulant
0,507  0,019  Antioxidant
0,497  0,012  Antihypertriglyceridemic
0,487  0,003  UGT2B9 substrate
0,480  0,003  Anticataract
0,482  0,014  UGT1A6 substrate
0,511  0,056  Caspase 9 stimulant
0,461  0,007  Amylase inhibitor
0,462  0,009  Hepatoprotectant
0,451  0,001  5-Alpha-reductase inhibitor
0,467  0,023  Metabolic disease treatment
0,448  0,005  Lipocortins synthesis antagonist
0,436  0,004  Contraceptive female
0,457  0,027  AR expression inhibitor
0,429  0,005  Diabetic nephropathy treatment
0,427  0,003  Farnesoid X receptor antagonist
0,419  0,005  Neurotrophic factor
0,438  0,030  Antineoplastic (brain cancer)
0,431  0,031  Antihypertensive
0,402  0,005  Antiinfertility, female
0,418  0,022  Antidiabetic symptomatic
0,414  0,024  Renal disease treatment
0,428  0,046  Stroke treatment
0,407  0,034  UGT1A9 substrate
0,372  0,002  5-Alpha-reductase 2 inhibitor
0,371  0,001  Glycine receptor agonist
0,377  0,008  Antiviral (Influenza A)
0,386  0,017  Skin irritative effect
0,405  0,038  ICAM1 expression inhibitor
0,395  0,033  Antidiabetic (type 2)
0,363  0,002  5-Alpha-reductase 1 inhibitor
0,380  0,019  Antihelmintic
0,389  0,031  Free radical scavenger
0,371  0,014  Antiviral (Influenza)
0,365  0,011  UGT2B15 substrate
0,380  0,028  Antineoplastic (renal cancer)
0,362  0,013  Phospholipase C inhibitor
0,359  0,014  UGT1A3 substrate
0,369  0,029  Antiparasitic
0,344  0,007  Psychosexual dysfunction treatment
0,340  0,005  Retinoprotector
0,400  0,065  Antineoplastic (lung cancer)
0,353  0,037  Antineoplastic (lymphoma)
0,318  0,004  UGT2B10 substrate
0,358  0,044  Antineoplastic (glioma)
0,325  0,014  Liver fibrosis treatment
0,372  0,062  Inflammatory Bowel disease treatment
0,324  0,014  NOS3 expression enhancer
0,390  0,081  Antibacterial
0,312  0,005  Alcohol dehydrogenase substrate
0,320  0,015  Bone formation stimulant
0,309  0,008  Interleukin 4 antagonist
0,296  0,003  Hyperparathyroidism treatment
0,346  0,055  Antineoplastic (melanoma)
0,297  0,011  Protein-tyrosine phosphatase 1B inhibitor
0,296  0,010  Endometrios treatment
0,288  0,002  RNA-directed RNA polymerase stimulant
0,288  0,003  Androgen agonist
0,389  0,112  Antineoplastic (solid tumors)
0,296  0,020  Protein-tyrosine phosphatase inhibitor
0,318  0,043  Angiogenesis stimulant
0,324  0,050  Antineoplastic (endocrine cancer)
0,293  0,020  Lipid peroxidase inhibitor
0,293  0,020  Neurotrophic factor enhancer
0,315  0,043  Antineoplastic (glioblastoma multiforme)
0,274  0,003  Bile acid receptor antagonist
0,275  0,004  Actinic keratosis treatment
0,321  0,052  Antineoplastic (cervical cancer)
0,269  0,003  Arachidonic acid antagonist
0,274  0,010  Liver cirrhosis treatment
0,268  0,008  Contraceptive male
0,278  0,022  Skin whitener
0,289  0,034  Muscle relaxant
0,265  0,015  Antifungal enhancer
0,252  0,006  Hedgehog signaling inhibitor
0,250  0,004  Hypercalcemia treatment
0,271  0,026  Melanin inhibitor
0,256  0,018  LDLR expression enhancer
0,312  0,075  CYP2D6 substrate
0,240  0,006  ABCA1 expression enhancer
0,291  0,057  Tumour necrosis factor alpha release inhibitor
0,275  0,043  Antineoplastic enhancer
0,286  0,061  Antipyretic
0,250  0,026  Protein kinase stimulant
0,234  0,013  Microtubule formation inhibitor
0,232  0,011  Choleretic
0,242  0,022  Toxic, respiratory center
0,279  0,059  Vascular (periferal) disease treatment
0,221  0,003  Anticholelithogenic
0,221  0,004  Liver X receptor agonist
0,226  0,009  HDL-cholesterol increasing
0,223  0,007  Postmenopausal disorders treatment
0,218  0,003  UGT2B11 substrate
0,222  0,008  Aromatase inhibitor
0,218  0,007  Inducible nitric-oxide synthase inhibitor
0,215  0,005  CDC25A inhibitor
0,227  0,017  Antineoplastic antibiotic
0,270  0,061  Cardiodepressant
0,212  0,003  Anabolic
0,238  0,031  Skeletal muscle relaxant
0,209  0,003  Glycine receptor antagonist
0,209  0,013  Growth stimulant
0,233  0,040  Growth factor agonist
0,200  0,008  Estrogen agonist
0,240  0,052  Antialcoholic
0,182  0,002  Vitamin D receptor antagonist
0,179  0,003  Na+ K+ transporting ATPase inhibitor
0,208  0,031  Monophenol monooxygenase inhibitor
0,233  0,057  Sedative
0,175  0,001  Hedgehog signaling activator
0,249  0,075  Myocardial infarction treatment
0,255  0,089  Spasmolytic
0,206  0,044  Antiviral (Herpes)
0,207  0,048  Eye irritation, high
0,217  0,063  Platelet adhesion inhibitor
0,171  0,021  Antineoplastic, alkylator
0,167  0,018  Estrogen antagonist
0,161  0,013  SULT1E1 substrate
0,149  0,005  Estrogen receptor alpha agonist
0,243  0,100  Cardioprotectant
0,216  0,077  Antiulcerative
0,142  0,009  Cushing's syndrome treatment
0,140  0,008  Estrogen receptor beta agonist
0,132  0,001  Vitamin D receptor agonist
0,146  0,016  Paget's disease treatment
0,239  0,110  Hypoxia-inducible factor 1 alpha inhibitor
0,183  0,056  Muscular dystrophy treatment
0,180  0,052  Acute respiratory distress syndrome (ARDS) treatment
0,141  0,015  Lanosterol 14 alpha demethylase inhibitor
0,236  0,111  CYP1A2 substrate
0,193  0,071  Mutagenic
0,154  0,033  SULT1A1 substrate
0,160  0,039  Antihemorrhagic
0,120  0,002  Parathyroid hormone antagonist
0,189  0,072  P-glycoprotein inhibitor
0,152  0,037  Menstruation disorders treatment
0,217  0,102  Antineoplastic (sarcoma)
0,112  0,004  Lipocortins synthesis agonist
0,118  0,014  SULT1A2 substrate
0,125  0,027  Estrogen receptor beta antagonist
0,100  0,003  Glucose-6-phosphate dehydrogenase inhibitor
0,149  0,056  Antieczematic
0,173  0,081  Diabetic retinopathy treatment
0,127  0,036  Interleukin 2 antagonist
0,094  0,004  Farnesoid X receptor agonist
0,109  0,020  Premenstrual syndrome treatment
0,213  0,125  Antineoplastic (colorectal cancer)
0,153  0,065  Hemostatic
0,205  0,120  Antineoplastic (colon cancer)
0,190  0,106  Antiprotozoal (Leishmania)
0,163  0,080  Antipruritic
0,091  0,009  Aldosterone antagonist
0,149  0,068  Antidiabetic (type 1)
0,118  0,040  Prolactin inhibitor
0,193  0,116  Antihypotensive
0,082  0,005  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,102  0,025  Estrogen receptor alpha antagonist
0,080  0,004  Cholesterol absorption inhibitor
0,082  0,006  Glucocorticoid antagonist
0,089  0,015  SULT2A1 substrate
0,104  0,029  Vanilloid agonist
0,183  0,111  Antiviral (HIV)
0,121  0,049  Neutropenia treatment
0,082  0,012  Postcoital contraceptive
0,146  0,078  Phospholipase A2 inhibitor
0,143  0,075  Adenylate cyclase stimulant
0,186  0,119  Cardiovascular analeptic
0,118  0,050  AMP-activated protein kinase stimulant
0,183  0,118  Cytostatic
0,068  0,004  HMG CoA reductase inhibitor
0,080  0,019  Andropause treatment
0,112  0,053  Toll-Like receptor 4 antagonist
0,098  0,041  Transcription factor NF kappa B stimulant
0,060  0,004  CYP24 inhibitor
0,187  0,133  5 Hydroxytryptamine release stimulant
0,062  0,009  Hypogonadism treatment
0,126  0,074  Vanilloid 1 agonist
0,066  0,016  Mineralocorticoid receptor antagonist
0,118  0,068  Anesthetic local
0,056  0,009  Liver X receptor beta agonist
0,060  0,015  Microtubule stabilization
0,209  0,165  Multiple sclerosis treatment
0,107  0,063  Glutathione S-transferase substrate
0,069  0,026  Heme oxygenase stimulant
0,075  0,032  CDC25B inhibitor
0,050  0,007  Estrone sulfatase inhibitor
0,085  0,043  Antibiotic
0,056  0,016  Progesterone antagonist
0,044  0,004  Corticosteroid-like
0,045  0,005  Glucocorticoid agonist
0,133  0,094  Insulin secretagoues
0,114  0,075  Carcinogenic, group 3
0,142  0,103  Interleukin 6 antagonist
0,102  0,064  Protease inhibitor
0,060  0,023  Anesthetic inhalation
0,234  0,198  Analgesic
0,063  0,027  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,040  0,005  Progesterone agonist
0,193  0,159  Gastrin inhibitor
0,044  0,010  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,074  0,041  Vanilloid 1 antagonist
0,174  0,142  Hypoglycemic
0,085  0,053  Estrogen-related receptor beta agonist
0,130  0,100  Antifungal (Cryptococcus)
0,114  0,084  Cyclooxygenase 3 inhibitor
0,077  0,048  Antitreponemal
0,035  0,006  1,3-Beta-glucan synthase inhibitor
0,030  0,005  Ileal bile acid transport inhibitor
0,056  0,036  Angiotensin-converting enzyme inhibitor
0,082  0,063  Antineoplastic alkaloid
0,020  0,001  Vitamin D-like
0,024  0,008  Apical sodium codependent bile acid transporter inhibitor
0,017  0,001  Transcortin receptor antagonist
0,018  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,083  0,072  ATPase (Vacuolar H+) inhibitor
0,219  0,210  CYP2C19 inhibitor
0,135  0,126  Wound healing agent
0,018  0,010  Telomerase stimulant
0,121  0,114  Antidiarrheal
0,058  0,051  Antimycoplasmal
0,139  0,134  Antiviral (Hepatitis)
0,039  0,036  HIV-1 protease inhibitor
0,218  0,216  Antiparkinsonian
0,084  0,083  Posttraumatic stress disorder treatment
0,027  0,026  Squalene synthetase inhibitor
0,056  0,056  Nitric oxide donor

